To confirm target engagement and pharmacodynamics for the TfR-siCEBPB conjugate on the PDAC animal model, liver and tumor tissues were processed and analyzed for CEBPA and CEBPB mRNA expression. The gene discussed is CEBPA; the disease is neoplasm.